Abstract
References
Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1985;3(1):33-69. Available from: https://doi.org/10.1016/0738-081x(85)90096-3
Lehmann AR. Nucleotide excision repair and the link with transcription. Trends Biochem Sci. 1995;20(10):402-5. Available from: https://doi.org/10.1016/s0968-0004(00)89088-x
Morrell D, Cromare E, Swift M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 1986;77:89-92.
Savitky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-1753. Available from: https://doi.org/10.1126/science.7792600
Hartley KO, Gell D, Smith GC, et al. DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene. Cell 1995;82:849-856. Available from: https://doi.org/10.1016/0092-8674(95)90482-4
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of the p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. Loss of p53 associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 1995;53:4164-4168.
Mcllwrath AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radio-sensitivity of human tumour cell lines: dependence on wild type p53 function. Cancer Res 1994;54:3718-3722.
Bischoff FZ, Yim SO, Pathak S, et al. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalisation. Cancer Research 1990;50:7979-7984
Eeles RA. Germline mutations in the TP53 gene. In: BAJ Ponder, WK Cavenee, E Soloman (Eds). Genetics and cancer: A second look. Cold Spring Harbor Press;1995:101-122
Harvey M, McArthur MJ, Montgomery CA, et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genetics 1993;5:225-229. Available from: https://doi.org/10.1038/ng1193-225
Kemp CJ, Wheldon T, Balmain A. p53 deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994;8:66-69. Available from: https://doi.org/10.1038/ng0994-66
Kolodner RD. Mismatch repair: mechanism and relationship to cancer susceptibility. TIBS 995;20:397-401
Eshleman JR, Lang EZ, Bowerfind GK, et al. Increased mutation rate at the hprt locus accompanies micro-satellite instability in colon cancer. Oncogene 1995;10: 33-37
Karran P, Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays 1994;16:833-839. Available from: https://doi.org/10.1002/bies.950161110
Parsons R, Li GM, Longley M, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995;268:738- 740. Available from: https://doi.org/10.1126/science.7632227
Parshad R, Sanford KK, Jones GM. Chromatid damage after G2 phase x-irradiation of cells from cancer prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci 1983;80:5612-5616. Available from: https://doi.org/10.1073/pnas.80.18.5612
Easton DF. Cancer risks in A-T heterozygotes. Int J Radiat Biol. 1994;66(6 Suppl):S177-82. Available from: https://doi.org/10.1080/09553009414552011
Blocher D, Sigut D, Hannan MA. Fibroblasts from ataxia telangiectasia (AT) and AT hetero-zygotes show an enhanced level of residual DNA double-strand break after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 1991;60:791-802. Available from: https://doi.org/10.1080/09553009114552601
Swift M. Ionizing radiation, breast cancer and ataxia-telangectasia. J Natl Cancer Inst 1994;21:1571-572. Available from: https://doi.org/10.1093/jnci/86.21.1571
Grossman L, Wei Q. DNA repair capacity (DRC) a a biomarker of human variational responses to the environment. In: Vos JH (Eds). DNA repair mechanisms: impact on human disease and cancer. R G Lande Company;1994:329-347
Szarka CE, Pfeiffer GR, Hum ST, et al. Glutathione S-transferase activity and glutathione S-transferase µ expression in subjects with risk for colorectal cancer. Cancer Res 1995;55:2789-2793.
Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTMI genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-1824. Available from: https://doi.org/10.1093/carcin/14.9.1821
Bouchardy C, Benhamou S, Dayer P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Research 1996;56:251-253.
Ambrosone CB, Marshall JR, et al. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk. Cancer Causes and Control 1995;6:407-415. Available from: https://doi.org/10.1007/BF00052180